Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Long-Term Deferred Tax (2018 - 2026)

Sensus Healthcare has reported Long-Term Deferred Tax over the past 8 years, most recently at $4.1 million for Q4 2025.

  • For Q4 2025, Long-Term Deferred Tax rose 84.45% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, up 84.45%, while the annual FY2025 figure was $4.1 million, 84.45% up from the prior year.
  • Long-Term Deferred Tax for Q4 2025 was $4.1 million at Sensus Healthcare, down from $4.2 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $4.2 million in Q3 2025 and troughed at $121000.0 in Q4 2021.
  • A 5-year average of $2.5 million and a median of $2.2 million in 2024 define the central range for Long-Term Deferred Tax.
  • Biggest five-year swings in Long-Term Deferred Tax: plummeted 97.48% in 2021 and later skyrocketed 1315.7% in 2022.
  • Year by year, Long-Term Deferred Tax stood at $121000.0 in 2021, then skyrocketed by 1315.7% to $1.7 million in 2022, then grew by 25.92% to $2.2 million in 2023, then grew by 2.83% to $2.2 million in 2024, then soared by 84.45% to $4.1 million in 2025.
  • Business Quant data shows Long-Term Deferred Tax for SRTS at $4.1 million in Q4 2025, $4.2 million in Q3 2025, and $2.8 million in Q2 2025.